Tasso was announced the winner of DPharm Idol Disrupt at the 9th annual DPharm: Disrupting Innovations to Advance Clinical Trials Conference. Tasso has a service that provides patient centric blood-sampling kits for use by participants in clinical trials. Tasso’s goal is to eliminate the need for site visits, and to lower the costs and inconvenience associated with traditional blood sampling methods. Tasso aims to provide a clinical trial participant a ready made kit for blood sampling with easy to understand instructions for at-home self blood sampling, much of the patient burden for gathering blood data is eliminated.
Tasso had six minutes to present their aims in disrupting the current paradigm of clinical trials, and pitch their product to DPharm’s esteemed panel of judges, which consisted of:
Sandra Freeman
GCO U.S. Director, MAO Supported Studies, Johnson & Johnson